Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.92+0.02 (+2.19%)
Close on Nov 20, 2026Market cap $47.99MP/E –Yield –
Rafael gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Rafael's gross profit for the twelve months ending Jan 31, 2025 was $477.00K. For fiscal 2024 it was $483.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | $483.00K | – |
| FY2022 | Jul 31, 2022 | -$3.09M | – |
| FY2021 | Jul 31, 2021 | -$2.37M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $39.00K | -45.1% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $91.00K | +30.0% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $96.00K | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $251.00K | – |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $71.00K | – |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $70.00K | – |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -$179.00K | – |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -$760.00K | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$723.00K | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$962.00K | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$644.00K | – |
See a number that looks wrong?